trending Market Intelligence /marketintelligence/en/news-insights/trending/pwvj02yhl7ez78iufxrfba2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Onconova Therapeutics receives Nasdaq noncompliance notice

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Onconova Therapeutics receives Nasdaq noncompliance notice

Onconova Therapeutics Inc. said it was no longer in compliance with Nasdaq's minimum closing bid listing requirement of $1 per share.

The Newtown, Pa.-based company has until Nov. 5 to regain compliance by attaining the closing bid price of at least $1 per share for a minimum of 10 consecutive business days.

Onconova said it intends to monitor its closing bid price and was considering options to resolve the noncompliance issue.